KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Non-Current Assets (2016 - 2025)

Eli Lilly (LLY) has disclosed Other Non-Current Assets for 17 consecutive years, with $7.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 22.24% year-over-year to $7.0 billion, compared with a TTM value of $7.0 billion through Dec 2025, up 22.24%, and an annual FY2025 reading of $7.0 billion, up 22.24% over the prior year.
  • Other Non-Current Assets was $7.0 billion for Q4 2025 at Eli Lilly, up from $6.4 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.0 billion in Q4 2025 and bottomed at $3.6 billion in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $4.9 billion, with a median of $4.7 billion recorded in 2023.
  • The sharpest move saw Other Non-Current Assets increased 4.27% in 2024, then grew 29.03% in 2025.
  • Year by year, Other Non-Current Assets stood at $4.1 billion in 2021, then rose by 6.23% to $4.3 billion in 2022, then rose by 15.05% to $5.0 billion in 2023, then grew by 14.63% to $5.7 billion in 2024, then rose by 22.24% to $7.0 billion in 2025.
  • Business Quant data shows Other Non-Current Assets for LLY at $7.0 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.2 billion in Q2 2025.